JPMorgan lowered the firm’s price target on Gentex (GNTX) to $32 from $34 and keeps a Neutral rating on the shares. The company reported a “surprisingly softer” set of Q4 results while also issuing 2025 guidance materially lower than consensus, the analyst tells investors in a research note. The firm says Gentex’s margin goal was again pushed out.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio